Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

44.44
Delayed Data
As of Jun 23
 +0.77 / +1.76%
Today’s Change
30.89
Today|||52-Week Range
57.41
+23.93%
Year-to-Date

Today’s Trading

Previous close43.67
Today’s open44.00
Day’s range43.90 - 44.55
Volume2,789,416
Average volume (3 months)2,327,123
Market cap$85.2B
Dividend yield3.02%
Data as of 4:02pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+10.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.67%
Revenue growth (last year)+3.81%
P/E ratio2.9
Price/Sales5.48
Price/Book17.33

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories-0.19-0.39%
AGNAllergan-0.65-0.26%
AZNAstraZeneca-0.29-0.82%
LLYEli Lilly and Co-0.42-0.50%
Data as of 4:03pm ET, 06/23/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)$0.56
Annual revenue (last year)$16.6B
Annual profit (last year)$5.6B
Net profit margin33.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts